Logo image of ANGO

ANGIODYNAMICS INC (ANGO) Stock Fundamental Analysis

NASDAQ:ANGO - US03475V1017 - Common Stock

9.45 USD
+0.38 (+4.19%)
Last: 8/22/2025, 8:00:00 PM
9.45 USD
0 (0%)
After Hours: 8/22/2025, 8:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ANGO. ANGO was compared to 187 industry peers in the Health Care Equipment & Supplies industry. ANGO has a bad profitability rating. Also its financial health evaluation is rather negative. ANGO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ANGO had negative earnings in the past year.
ANGO had a negative operating cash flow in the past year.
ANGO had negative earnings in each of the past 5 years.
In multiple years ANGO reported negative operating cash flow during the last 5 years.
ANGO Yearly Net Income VS EBIT VS OCF VS FCFANGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of ANGO (-12.13%) is comparable to the rest of the industry.
ANGO has a Return On Equity of -18.58%. This is in the better half of the industry: ANGO outperforms 60.43% of its industry peers.
Industry RankSector Rank
ROA -12.13%
ROE -18.58%
ROIC N/A
ROA(3y)-26.67%
ROA(5y)-18.08%
ROE(3y)-40.7%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ANGO Yearly ROA, ROE, ROICANGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

ANGO's Gross Margin of 53.92% is in line compared to the rest of the industry. ANGO outperforms 48.13% of its industry peers.
ANGO's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ANGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y-1.07%
ANGO Yearly Profit, Operating, Gross MarginsANGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

ANGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ANGO has more shares outstanding
The number of shares outstanding for ANGO has been increased compared to 5 years ago.
The debt/assets ratio for ANGO is higher compared to a year ago.
ANGO Yearly Shares OutstandingANGO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
ANGO Yearly Total Debt VS Total AssetsANGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

ANGO has an Altman-Z score of 1.38. This is a bad value and indicates that ANGO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.38, ANGO perfoms like the industry average, outperforming 56.15% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that ANGO is not too dependend on debt financing.
ANGO's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. ANGO outperforms 65.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 1.38
ROIC/WACCN/A
WACC8.87%
ANGO Yearly LT Debt VS Equity VS FCFANGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

ANGO has a Current Ratio of 2.21. This indicates that ANGO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ANGO (2.21) is comparable to the rest of the industry.
ANGO has a Quick Ratio of 1.40. This is a normal value and indicates that ANGO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.40, ANGO is doing worse than 62.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.4
ANGO Yearly Current Assets VS Current LiabilitesANGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.54% over the past year.
The Revenue has decreased by -3.76% in the past year.
The Revenue has been growing slightly by 2.06% on average over the past years.
EPS 1Y (TTM)61.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y-2.56%
Revenue growth 5Y2.06%
Sales Q2Q%12.93%

3.2 Future

ANGO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.78% yearly.
ANGO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.57% yearly.
EPS Next Y-110.8%
EPS Next 2Y17.81%
EPS Next 3Y70.91%
EPS Next 5Y54.78%
Revenue Next Year7.17%
Revenue Next 2Y6.72%
Revenue Next 3Y7.33%
Revenue Next 5Y7.57%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ANGO Yearly Revenue VS EstimatesANGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100M 200M 300M
ANGO Yearly EPS VS EstimatesANGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ANGO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANGO Price Earnings VS Forward Price EarningsANGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 -60

4.2 Price Multiples

61.50% of the companies in the same industry are more expensive than ANGO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 228.01
ANGO Per share dataANGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

ANGO's earnings are expected to grow with 70.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.81%
EPS Next 3Y70.91%

More info and screens

0

5. Dividend

5.1 Amount

ANGO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANGIODYNAMICS INC

NASDAQ:ANGO (8/22/2025, 8:00:00 PM)

After market: 9.45 0 (0%)

9.45

+0.38 (+4.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-15 2025-07-15/bmo
Earnings (Next)10-01 2025-10-01
Inst Owners93.13%
Inst Owner Change2.24%
Ins Owners6.51%
Ins Owner Change16.35%
Market Cap383.95M
Analysts84
Price Target18.61 (96.93%)
Short Float %9.8%
Short Ratio5.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)99.06%
Min EPS beat(2)75.49%
Max EPS beat(2)122.62%
EPS beat(4)4
Avg EPS beat(4)72.23%
Min EPS beat(4)26.47%
Max EPS beat(4)122.62%
EPS beat(8)7
Avg EPS beat(8)47.73%
EPS beat(12)8
Avg EPS beat(12)9.45%
EPS beat(16)11
Avg EPS beat(16)3.9%
Revenue beat(2)2
Avg Revenue beat(2)3.12%
Min Revenue beat(2)0.41%
Max Revenue beat(2)5.83%
Revenue beat(4)3
Avg Revenue beat(4)1.08%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)5.83%
Revenue beat(8)3
Avg Revenue beat(8)-0.79%
Revenue beat(12)3
Avg Revenue beat(12)-1.47%
Revenue beat(16)5
Avg Revenue beat(16)-0.99%
PT rev (1m)11.73%
PT rev (3m)16.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.08%
EPS NY rev (1m)-36.76%
EPS NY rev (3m)-36.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0.77%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.31
P/FCF N/A
P/OCF N/A
P/B 2.1
P/tB 3.37
EV/EBITDA 228.01
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS7.2
BVpS4.5
TBVpS2.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.13%
ROE -18.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.92%
FCFM N/A
ROA(3y)-26.67%
ROA(5y)-18.08%
ROE(3y)-40.7%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y-1.07%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 3.96
Cap/Depr 17.3%
Cap/Sales 1.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 1.4
Altman-Z 1.38
F-Score6
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)17.4%
Cap/Depr(5y)17.38%
Cap/Sales(3y)1.57%
Cap/Sales(5y)1.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y-110.8%
EPS Next 2Y17.81%
EPS Next 3Y70.91%
EPS Next 5Y54.78%
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y-2.56%
Revenue growth 5Y2.06%
Sales Q2Q%12.93%
Revenue Next Year7.17%
Revenue Next 2Y6.72%
Revenue Next 3Y7.33%
Revenue Next 5Y7.57%
EBIT growth 1Y29.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year129.56%
EBIT Next 3Y70.68%
EBIT Next 5Y53.73%
FCF growth 1Y56.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.03%
OCF growth 3YN/A
OCF growth 5YN/A